← Back to all trials
Completed
NCT05737173
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
Conditions: Osteo Arthritis Knee
Sex: All
Ages: 50 Years – 99 Years
Phase: PHASE2, PHASE3
Enrollment: 93
Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand
Location: Thailand
Summary
To compare the efficacy of intraarticular knee injection between leukocyte-rich and leukocyte-poor platelet-rich plasma in knee osteoarthritis treatment
Eligibility Criteria
Inclusion Criteria:Age greater than or equal to 50 years old, Plain radiographs knee AP shows Kellgren-Lawrence classification 1-4, Refuse the use of NSAIDs for 2 weeks.Exclusion Criteria:1) Previous intra-articular injection therapy in the past 6 months; 2) Previously treated with intra-knee PRP injection; 3) History of knee arthritis from other causes such as rheumatoid arthritis, pseudogout or infectious joints 4) History of blood disorder including anemia and thrombocytopenia (Hb < 12 g/dl, plt < 150,000/ml ) 5) History of surgery on the aforementioned knee 6) Obvious knee deformity (valgus > 15, varus > 20, flexion ROM < 90 , extension lag > 20) 7) Pregnancy and lactation
Source: ClinicalTrials.gov (NCT05737173). StuddyBuddy aggregates publicly available trial information.